Loading...
Uploaded by TheMedicineGuy on Jun 26, 2011
SmarterMeds Managing Member Aaron Emmel provides commentary about the new FDA warning about using erythropoietin stimulating agents to treat anemia in patients with chronic kidney disease.
News & Politics
Standard YouTube License
Load more suggestions
Link to this comment:
All Comments (0)